Cancer Cell Metabolic Machinery

The "cancer cell metabolic machinery" refers to the network of metabolic pathways and regulatory mechanisms that are reprogrammed in cancer cells to support their uncontrolled growth, survival, and adaptation. Unlike normal cells, cancer cells undergo profound changes in how they process nutrients and generate energy—a phenomenon known as metabolic reprogramming or the "Warburg Effect." This altered metabolism is a hallmark of cancer and underpins many aspects of tumor biology. Key features include aerobic glycolysis, altered TCA cycle usage, glutaminolysis, enhanced lipid metabolism, one-carbon metabolism, and pentose phosphate pathway activation. These metabolic changes are driven by oncogenes, tumor suppressors, and hypoxia-inducible factors and enable rapid biomass accumulation, redox homeostasis, and adaptation to harsh microenvironments. Several enzymes within these pathways are being explored as drug targets, but must be balanced against effects on normal proliferating tissues. It also contributes directly to therapy resistance and immune evasion.

Other names

Metabolic ReprogrammingWarburg EffectTumor Metabolism

Varies depending on the specific target within the metabolic machinery, but generally involves inhibiting key enzymes or pathways to disrupt cancer cell growth and survival.